Disney to split nearly $3B media business with Publicis and Omnicom
It draws a close to the biggest media pitch in recent years.
News
Johnson & Johnson earnings beat expectations despite legal hurdles
The company is facing thousands of lawsuits over talc and opioid products.
Five things for pharma marketers to know: Wednesday, October 16, 2019
Drug distributors in talks to settle opioid lawsuits for $18 billion; J&J Q3 earnings beat expectations; Ancestry launches genetic health testing.
‘Big six’ acquisitions set to sag to half the level of 2018
Dentsu is leading much-diminished deal-making activity by volume.
Omnicom falls short but still posts 2.2% organic growth in Q3
Organic growth was 3% in UK and 2.7% in US.
Analysts suggest Publicis ‘bitten off more than it can chew’ as shares dive 13%
Stock market movement follows decline in revenues reported last night.
Survey: Patients want more from pharma brand websites
Patients are looking for tools like doctor directories and the ability to book appointments on branded pharma websites.
Five things for pharma marketers to know: Tuesday, October 15, 2019
Nearly all patients with vaping illness end up in hospital; Purdue tries to halt opioid lawsuits; House panel requests marketing documents from e-cigarette Vuse.
Healthgrades pairs video content with HCP finder tools and reviews
The company’s PatientConnect Video draws on an extensive database and AI to dimensionalize marketing experiences beyond “go talk to your physician.”
PSA compares concussions in youth football to smoking
The Concussion Legacy Foundation and Fingerpaint are warning parents about the risks of tackle football before age 14.
Want to read more?
Please login or register first to view this content.
